TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth
Open accessThe DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Abstract
Malignant mesothelioma (MM) is an incurable malignancy that is caused by exposure to asbestos and is accompanied by severe fibrosis. Because MM is usually diagnosed at an advanced stage and clinical identification of early lesions is difficult, its molecular pathogenesis has not been completely elucidated. Nearly 75% of MM cases have inactivating mutations in the NF2 (neurofibromatosis type 2; Merlin) gene or in downstream signaling molecules of the Hippo signaling cascade, which negatively regulates the transcription factor Yes-associated protein (YAP). In this study, we demonstrate a functional interaction between the Hippo and TGF-β pathways in regulating connective tissue growth factor (CTGF). Expression of CTGF in MM cells was induced by the formation of a YAP-TEAD4-Smad3-p300 complex on the CTGF promoter. Knocking down CTGF expression in MM cells prolonged the survival of xenografted mice, and a significant association was seen between CTGF expression and extracellular matrix deposition in MM xenografts and in patient tissue specimens. We further suggest that CTGF may influence the malignancy of mesothelioma because of the different histological expression patterns observed in human MM tissues. These data suggest that CTGF is an important modulator of MM growth and pathology and represents a novel therapeutic target for this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As previously mentioned in this review, TGF-β itself and its family members have been recognized to be involved in cancer development [81], and TGF-β possesses a pro-oncogenic role in MPM connected to immune suppression [82,83].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [83]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907 · cited 1×
“Subsequent studies further revealed that TGF- acts as a tumor suppressor in premalignant cells as well as cells progressing through the early stages of carcinogenesis; furthermore, it exerts prooncogenic effects in metastatic tumors (Roberts and Wakefield, 2003; Massagué, 2008).”
BackgroundTEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498 · cited 6×
“In addition to recent studies that indicate that tumor cell–derived CTGF plays an important role in the proliferation of breast cancer cells (Zhao et al., 2008) and growth of pancreatic tumors (Bennewith et al.”
BackgroundMethodInfluentialMassagué, J., Seoane, J., & Wotton, D. (2005) · Genes & Development · doi:10.1101/gad.1350705 · Cited by 2,452
Elucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
Growth factors from murine sarcoma virus-transformed cells.
de Larco, J. E., & Todaro, G. J. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.8.4001 · Cited by 1,461
Wu, S., Huang, J., Dong, J., & Pan, D. (2003) · Cell · doi:10.1016/s0092-8674(03)00549-x · Cited by 1,098
Advances in Malignant Mesothelioma
Robinson, B. W. S., & Lake, R. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050152 · Cited by 889
Zhang, N., Bai, H., David, K. K., Dong, J., Zheng, Y., Cai, J., Giovannini, M., Liu, P., Anders, R. A., & Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.06.015 · Cited by 804
Hamaratoglu, F., Willecke, M., Kango-Singh, M., Nolo, R., Hyun, E., Tao, C., Jafar-Nejad, H., & Halder, G. (2006) · Nature Cell Biology · doi:10.1038/ncb1339 · Cited by 767
Cited by
Items 101–200 of 245
TEAD4 as an Oncogene and a Mitochondrial Modulator
Hsu, S., Lin, C., Lin, Y., Collins, C. C., Chen, C., & Kung, H. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.890419 · Cited by 38
Ramírez-Salazar, E. G., Salinas-Silva, L. C., Vázquez-Manríquez, M. E., Gayosso-Gómez, L. V., Negrete-García, M. C., Ramírez-Rodriguez, S. L., Chávez, R., Zenteno, E., Santillán, P., Kelly-García, J., et al. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2014.09.016 · Cited by 37
Zearalenone exposure elevated the expression of tumorigenesis genes in mouse ovarian granulosa cells
Zhang, R., Sun, X., Wu, R.-Y., Cheng, S., Zhang, G.-L., Zhai, Q., Liu, X., Zhao, Y. M., Shen, W., & Li, L. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.08.013 · Cited by 37
Gu, K., Fu, X., Tian, H., Zhang, Y., Li, A., Wang, Y., Wen, Y., & Gu, W. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29346 · Cited by 36
CRISPR screens identify tumor‐promoting genes conferring melanoma cell plasticity and resistance
Gautron, A., Bachelot, L., Aubry, M., Leclerc, D., Quéméner, A. M., Corre, S., Rambow, F., Paris, A., Tardif, N., Leclair, H. M., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013466 · Cited by 37
Jiang, L., Yamashita, Y., Chew, S., Akatsuka, S., Ukai, S., Wang, S., Nagai, H., Okazaki, Y., Takahashi, T., & Toyokuni, S. (2014) · The Journal of Pathology · doi:10.1002/path.4377 · Cited by 34
Chen, Y., Wei, G., Xia, H., Yu, H., Tang, Q., & Bi, F. (2017) · Oncotarget · doi:10.18632/oncotarget.19130 · Cited by 33
Recent advances in understanding contextual TGFβ signaling
Ayyaz, A., Attisano, L., & Wrana, J. L. (2017) · F1000Research · doi:10.12688/f1000research.11295.1 · Cited by 32
Zheng, M., Jacob, J., Hung, S.-H., & Wang, J. (2020) · Biomolecules · doi:10.3390/biom10071024 · Cited by 31
Córdova, G., Rochard, A., Riquelme‐Guzmán, C., Cofré, C., Scherman, D., Bigey, P., & Brandan, E. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25143 · Cited by 31
Integrin‐FAK‐CDC42‐PP1A signaling gnaws at YAP/TAZ activity to control incisor stem cells
Hicks‐Berthet, J., & Varelas, X. (2017) · BioEssays · doi:10.1002/bies.201700116 · Cited by 31
Downregulation of VGLL4 in the progression of esophageal squamous cell carcinoma
Jiang, W., Yao, F., He, J., Lv, B., Fang, W., Zhu, W., He, G., Chen, J., & He, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-2701-7 · Cited by 30
Liang, Z., Wang, Y., Shen, Z., Teng, X.-M., Li, X., Li, C., Wu, W., Zhou, Z., & Wang, Z. (2016) · Tumor Biology · doi:10.1007/s13277-016-4934-0 · Cited by 30
Ikeno, S., Nakano, N., Sano, K., Minowa, T., Sato, W., Akatsu, R., Sakata, N., Hanagata, N., Fujii, M., Itoh, F., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004153 · Cited by 30
Self-citationWang, M., Li, X., Zhang, M., Ye, Q.-Y., Chen, Y.-X., & Xu, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.738534 · Cited by 29
Zhang, X., Fan, Q., Li, Y., Yang, Z., Yang, L., Zong, Z., Wang, B., Meng, X., Li, Q., Liu, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14523 · Cited by 29
Matsushita, A., Sato, T., Mukai, S., Fujishita, T., Mishiro‐Sato, E., Okuda, M., Aoki, M., Hasegawa, Y., & Sekido, Y. (2018) · Oncogene · doi:10.1038/s41388-018-0417-7 · Cited by 29
Self-citationWang, D., Lin, L., Lei, K., Zeng, J., Luo, J., Yin, Y., Li, Y., Zhang, L., Nie, X., Zuo, D., et al. (2020) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2020.08.015 · Cited by 29
Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma
Hayashi, H., Uemura, N., Liu, Z., Matsumura, K., Sato, H., Shiraishi, Y., & Baba, H. A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.700315 · Cited by 29
Zhou, Y., Yu, Y., Yang, H., Yang, H. K., Huo, Y., Huang, Y. X. R., Tian, X., & Fang, W. (2022) · Cancer Science · doi:10.1111/cas.15375 · Cited by 28
Hippo/YAP signaling’s multifaceted crosstalk in cancer
Zhang, J., Wu, H., Ren, X., Chen, Z., Ye, S., Chen, S., Fang, J., Wu, Q., & Zhao, T. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1595362 · Cited by 27
Zhang, C., Wei, W., Tu, S., Liang, B., Chun, L., Li, Y., Luo, W., Wu, Y., Dai, X., Wang, Y., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107208 · Cited by 28
Abd‐Elmawla, M. A., Mageed, S. S. A., AL‐Noshokaty, T. M., Elballal, M. S., Abulsoud, A. I., Elshaer, S. S., El-Husseiny, A. A., Fathi, D., Midan, H. M., Rizk, N. I., et al. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154817 · Cited by 26
YAP/TAZ: a promising target for squamous cell carcinoma treatment
Dong, X., Meng, L., Liu, P., Ji, R., Su, X., Xin, Y., & Jiang, X. M. (2019) · Cancer Management and Research · doi:10.2147/cmar.s197921 · Cited by 26
Stockhammer, P., Plönes, T., Theegarten, D., Schüler, M., Maier, S. M., Aigner, C., & Hegedűs, B. (2019) · Lung Cancer · doi:10.1016/j.lungcan.2019.11.013 · Cited by 27
Grzes, M., Oroń, M., Staszczak, Z., Jaiswar, A., Nowak-Niezgoda, M., & Walerych, D. (2020) · Cancers · doi:10.3390/cancers12061532 · Cited by 26
Kunnen, S. J., Malas, T. B., Formica, C., Leonhard, W. N., Hoen, P. A. C. ’., & Peters, D. J. M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.178 · Cited by 26
Thongon, N., Castiglioni, I., Zucal, C., Latorre, E., D’Agostino, V., Bauer, I., Pancher, M., Ballestrero, A., Feldmann, G., Nencioni, A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8437 · Cited by 24
Mimoun, S. B., & Mauviel, A. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.03.006 · Cited by 24
Khanal, P., Yeung, B., Zhao, Y., & Yang, X. (2019) · Scientific Reports · doi:10.1038/s41598-019-42767-w · Cited by 24
Pan-cancer analysis, cell and animal experiments revealing TEAD4 as a tumor promoter in ccRCC
Li, F., Feng, Y., Jiang, Q., Zhang, J., Wu, F., Li, Q., Jing, X., Wang, X., & Huang, C. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120327 · Cited by 24
Maeda, M., Chen, Y., Hayashi, H., Kumagai-Τakei, N., Matsuzaki, H., LEE, S., Nishimura, Y., & Otsuki, T. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2682 · Cited by 24
Napoli, F., Listì, A., Zambelli, V., Witel, G., Bironzo, P., Papotti, M., Volante, M., Scagliotti, G., & Righi, L. (2021) · Cancers · doi:10.3390/cancers13112564 · Cited by 22
“Furthermore, connective tissue growth factor (CTGF), a pro-tumorigenic CAF marker [49], is more expressed in sarcomatoid than in epithelioid MPM [61], and it is produced by both MPM cells and fibroblasts, and promotes the invasion of MPM cells in vitro [62].”
BackgroundCappellesso, R., Galasso, M., Nicolè, L., Dabrilli, P., Volinia, S., & Fassina, A. (2017) · Cancer Cytopathology · doi:10.1002/cncy.21869 · Cited by 22
Preisser, F., Giehl, K., Rehm, M., & Goppelt‐Struebe, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.05.001 · Cited by 20
Zhang, Y., Yan, S., Li, Y., Zhang, J., Luo, Y., Li, P., Yang, Y., Li, Y., Huang, Y., & Wang, E. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12429 · Cited by 19
Guo, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.862791 · Cited by 19
The 9p21.3 risk locus for coronary artery disease: A 10-year search for its mechanism
Almontashiri, N. A. M. (2017) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2017.03.001 · Cited by 18
Tanaka, M., Miura, Y., Numanami, H., Karnan, S., Ota, A., Konishi, H., Hosokawa, Y., & Hanyuda, M. (2015) · Oncology Reports · doi:10.3892/or.2015.4155 · Cited by 17
Zhou, J., Sun, X., Yang, L., Wang, L., Ran, G., Wang, J., Cao, Q., Wu, L., Bryant, A., Ling, C., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902382r · Cited by 16
O-GlcNAcylation controls pro-fibrotic transcriptional regulatory signaling in myofibroblasts
Very, N., Boulet, C., Gheeraert, C., Berthier, A., Johanns, M., Saleh, M. B., Guille, L., Bray, F., Strub, J., Bobowski, M., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06773-9 · Cited by 15
Sa-Ngiamwibool, P., Hamasaki, M., Kinoshita, Y., Matsumoto, S., Sato, A., Tsujimura, T., Kasai, T., Hiroshima, K., Kushitani, K., Takeshima, Y., et al. (2022) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2022.152004 · Cited by 15
Self-citationThe hippo pathway provides novel insights into lung cancer and mesothelioma treatment
Liu, X., Zuo, R. M., & Ou, W. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2727-0 · Cited by 15
Wu, L., Dell’Anno, I., Lapidot, M., Sekido, Y., Chan, M.-L., Kohno, M., Serre‐Beinier, V., Felley‐Bosco, E., & de Perrot, M. E. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.11.034 · Cited by 15
Self-citationSmads and cell fate: Distinct roles in specification, development, and tumorigenesis in the testis
Itman, C., & Loveland, K. L. (2013) · IUBMB Life · doi:10.1002/iub.1115 · Cited by 15
Luo, W., Li, Y., Zeng, Y. A., Li, Y., Cheng, M., Zhang, C., Li, F., Wu, Y., Huang, C., Yang, X., et al. (2023) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjad010 · Cited by 14
Verteporfin inhibits TGF-β signaling by disrupting the Smad2/3–Smad4 interaction
Nong, J., Shen, S., Hong, F., Xiao, F., Meng, L., Li, P., Lei, X., & Chen, Y. (2024) · Molecular Biology of the Cell · doi:10.1091/mbc.e24-02-0073 · Cited by 14
Exploration of a new drug that targets YAP
Fujii, M. (2012) · The Journal of Biochemistry · doi:10.1093/jb/mvs072 · Cited by 14
Self-citationCTGF (CCN2): a multifaceted mediator in breast cancer progression and therapeutic targeting
Ghosh, P., Dey, A., Nandi, S., Majumder, R., Das, S., & Mandal, M. (2025) · Cancer and Metastasis Reviews · doi:10.1007/s10555-025-10248-4 · Cited by 13
Narciclasine is a novel YAP inhibitor that disturbs interaction between YAP and TEAD4
Kawamoto, R., Nakano, N., Ishikawa, H., Tashiro, E., Nagano, W., Sano, K., Irie, M., Ikuta, M., Kishi, F., Nakane, T., et al. (2021) · BBA Advances · doi:10.1016/j.bbadva.2021.100008 · Cited by 13
Otsuki, H., Uemori, T., Inai, Y., Suzuki, Y., Araki, T., Nan‐ya, K., & Yoshinari, K. (2024) · The Journal of Toxicological Sciences · doi:10.2131/jts.49.175 · Cited by 13
Li, C., Peng, Z., Wang, Y., Lam, G., Nissen, N. N., Tang, J., Yuan, X., Lewis, M. S., Greene, M. I., Pandol, S. J., et al. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00185.2020 · Cited by 13
Yang, X., Delsante, M., Daneshpajouhnejad, P., Fenaroli, P., Mandell, K. A. P., Wang, X., Takahashi, S., Halushka, M. K., Kopp, J. B., Levi, M., et al. (2024) · Laboratory Investigation · doi:10.1016/j.labinv.2024.100336 · Cited by 12
He, X., Ballestas, E. R., Zeng, L., Zhang, T., McEvoy, C. M., Misra, P. S., Ki, V., Apostol, A. J., Wong, J., Meliambro, K. A., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adq3852 · Cited by 12
Aoyama, S., Kido, Y., Kanamoto, M., Naito, M., Nakanishi, M., Kanna, M., Yamamotoya, T., Asano, T., & Nakatsu, Y. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113544 · Cited by 12
Frequent homozygous deletion of Cdkn2a/2b in tremolite‐induced malignant mesothelioma in rats
Okazaki, Y., Misawa, N., Akatsuka, S., Kohyama, N., Sekido, Y., Takahashi, T., & Toyokuni, S. (2020) · Cancer Science · doi:10.1111/cas.14358 · Cited by 12
Self-citationOkazaki, Y. (2021) · Pathology International · doi:10.1111/pin.13196 · Cited by 12
Mouse Models of Mesothelioma: Strengths, Limitations and Clinical Translation
Robinson, C., Solin, J. N., Lee, G., Lake, R., & Lesterhuis, W. J. (2014) · Lung Cancer Management · doi:10.2217/lmt.14.27 · Cited by 11
Sato, T., Nakanishi, H., Akao, K., Okuda, M., Mukai, S., Kiyono, T., & Sekido, Y. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02248-5 · Cited by 11
Self-citationGhomlaghi, M., Theocharous, M., Hoang, N., Shin, S., von Kriegsheim, A., Neill, E. O., Zhang, T., & Nguyen, L. K. (2024) · iScience · doi:10.1016/j.isci.2024.109031 · Cited by 10
Hojo, M., Yamamoto, Y., Sakamoto, Y., Maeno, A., Ohnuki, A., Suzuki, J., Inomata, A., Moriyasu, T., Taquahashi, Y., Kanno, J., et al. (2021) · Cancer Science · doi:10.1111/cas.14873 · Cited by 10
Blackshear, P. E., Pandiri, A. R., Nagai, H., Bhusari, S. S., Hong, H. L., Ton, T.-V. T., Clayton, N. P., Wyde, M. E., Shockley, K. R., Peddada, S. D., et al. (2014) · Toxicologic Pathology · doi:10.1177/0192623314537885 · Cited by 10
Wei, S., Dai, W., Zhang, M., Wang, H., & Yang, X. (2021) · Computational and Mathematical Methods in Medicine · doi:10.1155/2021/1812227 · Cited by 10
Brčić, L., Mathilakathu, A., Walter, R. F. H., Wessolly, M., Mairinger, E., Beckert, H., Kreidt, D., Steinborn, J., Hager, T., Christoph, D. C., et al. (2021) · Cancers · doi:10.3390/cancers13081761 · Cited by 9
Prognostic Value of TGF-β Expression in Bladder Cancer: A Systematic Review and Meta-analysis
Kianmehr, S., Vahabirad, M., Seghatoleslam, A., Sadeghi, E., Kiani, R., & Ghasemi, H. (2024) · Urology Research and Practice · doi:10.5152/tud.2024.24024 · Cited by 8
Garoffolo, G., Sluiter, T. J., Thomas, A. C., Piacentini, L., Ruiter, M. S., Schiavo, A., Salvi, M., Saccu, C., Zoli, S., Chiesa, M., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.037531 · Cited by 8
Li, H., Kan, B., Song, L., Liu, Y., & Jian, X. (2020) · Journal of International Medical Research · doi:10.1177/0300060520905425 · Cited by 8
Chen, X.-X., Li, S., Yu, Z., & Tan, W. (2019) · Europe PMC (PubMed Central) · Cited by 8
Recent advances on Hippo-YAP pathway in skin diseases
Cai, X., Chen, K., Li, X., Zhang, K., Gu, J., Shen, C., Yu, B., & Huang, C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1728064 · Cited by 7
YAP1 expression in colorectal cancer confers the aggressive phenotypes via its target genes
Chen, H., Shang, Y., Li, X., & Wang, R. (2024) · Cell Cycle · doi:10.1080/15384101.2024.2309017 · Cited by 7
Wang, S., Shao, D., Gao, X., Zhao, P., Kong, F., Deng, J., Yang, L., Shang, W., Sun, Y., & Fu, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1480701 · Cited by 7
CD47-mediated regulation of glucose and lipid metabolism: implications for the pathogenesis of MASLD
Jiang, X., Zhao, W., Shen, B., Han, Y., & Chen, K. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1535382 · Cited by 7
Hybrid molecule between platanic acid and LCL-161 as a yes-associated protein degrader
Nakano, N., Fukuda, K., Tashiro, E., Ishikawa, H., Nagano, W., Kawamoto, R., Mori, A., Watanabe, M., Yamasaki, R., Nakane, T., et al. (2022) · The Journal of Biochemistry · doi:10.1093/jb/mvac021 · Cited by 7
Ghassemi, H., Hashemnia, M., Mousavi‐Bahar, S. H., Hosseini, H. M., & Mirhosseini, S. A. (2021) · PubMed Central · doi:10.22074/cellj.2021.7661 · Cited by 7
The TGFβ→TAK1→LATS→YAP1 Pathway Regulates the Spatiotemporal Dynamics of YAP1
Kim, M., Han, S.-H., Park, T.-G., Song, S.-H., Lee, J.-Y., Lee, Y., Yoo, S.-Y., Chi, X., Kim, E., Jang, J., et al. (2023) · Molecules and Cells · doi:10.14348/molcells.2023.0088 · Cited by 6
Cytoplasmatic and Nuclear YAP1 and pYAP1 Staining in Urothelial Bladder Cancer
Latz, S., Umbach, T., Goltz, D., Kristiansen, G., Müller, S. C., & Ellinger, J. (2015) · Urologia Internationalis · doi:10.1159/000438868 · Cited by 6
Assié, J., Meiller, C., Stern, E., Lasvergnas, J., Arnould, M., Pan, L., Montagne, F., Sequeiros, R., Zreibi, C. A., Nery, E. D., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-3822 · Cited by 6
Genome-Wide Profiling Reveals Novel microRNAs in Hand-Spinning-Specific Chrysotile Exposure
Jia, J., Guo, X., Feng, L., Yin, X., Zhu, L., Li, J., Yu, D., Fang, Y., Jiang, Z., Yu, M., et al. (2019) · Epigenomics · doi:10.2217/epi-2018-0143 · Cited by 5
Kreienbühl, J., Changkhong, S., Orlowski, V., Kirschner, M. B., Opitz, I., & Meerang, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713410 · Cited by 5
A gene signature linked to fibroblast differentiation for prognostic prediction of mesothelioma
Liu, J., Lu, Y., Liu, Y., Zhang, W. Y., Xian, S., Wang, S., Zheng, Z., Lin, R., Jin, M., Zhang, M., et al. (2024) · Cell & Bioscience · doi:10.1186/s13578-023-01180-7 · Cited by 5
Temporal and spatial expression of Smads and their correlation with YAP1 expression in sheep
Gao, W., Su, R., Sun, W., Wang, Q. Z., Lv, X. Y., Bao, J. J., Yu, J., Wang, L. H., Musa, H. H., & Chen, L. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15037715 · Cited by 5
How Inhaled Asbestos Causes Scarring and Cancer
Brody, A. R. (2018) · Current Respiratory Medicine Reviews · doi:10.2174/1573398x15666181231145538 · Cited by 5
Comparative proteomics reveals elevated CCN2 in NGLY1-deficient cells
Hetz, R., Magaway, C., Everett, J., Li, L., Willard, B. B., Freeze, H. H., & He, P. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.09.100 · Cited by 5
Itoh, Y., Miyake, K., Koinuma, D., Omata, C., Saitoh, M., & Miyazawa, K. (2024) · The FASEB Journal · doi:10.1096/fj.202400978r · Cited by 3
Ghanbari, M., Haghi, M., Safaralizadeh, R., Baradaran, B., & Feizi, M. A. H. (2025) · Medical Oncology · doi:10.1007/s12032-025-03134-0 · Cited by 3
Non-canonical Roles for the Hippo Pathway
Varelas, X. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6220-0_17 · Cited by 3
López, J. J. A. (2016) · Hispania Sacra · doi:10.3989/hs.2016.043 · Cited by 3
Hoang, N. T. D., Hassan, G., Suehiro, T., Mine, Y., Matsuki, T., & Fujii, M. (2022) · BMC Cancer · doi:10.1186/s12885-022-10080-x · Cited by 3
Self-citationGenetic dependencies associated with transcription factor activities in human cancer cell lines
Thatikonda, V., Supper, V., Wachter, J., Kaya, O., Kombara, A., Bilgilier, C., Ravichandran, M. C., Lipp, J., Sharma, R., Badertscher, L., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114175 · Cited by 3
TAZ/TEAD complex regulates TGF-β1-mediated fibrosis in iPSC-derived renal organoidsPreprint
Yang, X., Delsante, M., Daneshpajouhnejad, P., Fenaroli, P., Mandell, K. A. P., Wang, X. X., Takahashi, S., Halushka, M. K., Kopp, J. B., Levi, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.15.440011 · Cited by 3
Zhuang, C., Liu, Y., Fu, S., Yuan, C., Luo, J., Huang, X., Yang, W., Xie, W., & Zhuang, C. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.664616 · Cited by 3
Zgórzyńska, E. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083672 · Cited by 2
Yuan, L. Y., Wu, S., Yuan-Peng, Z., Jiang, T., Xia, W., & He, Y.-Q. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/3798694 · Cited by 2
The Role of Hippo/YAP Pathway in the Crosstalk of Tumor Cell Signaling Pathways
王, 莹. (2023) · Hans Journal of Biomedicine · doi:10.12677/hjbm.2023.131010 · Cited by 2
Xiao, Y., Wang, Y., Zhang, M., Zhang, Y., Ju, Z., Wang, J., Zhang, Y., Yang, C., Wang, X., Jiang, Q., et al. (2024) · Theriogenology · doi:10.1016/j.theriogenology.2024.11.010 · Cited by 2
Takehara, Y., Yamochi, T., Nagumo, T., Cho, T., Urushibara, F., Ono, K., Fujii, T., Okamoto, N., Sasaki, Y., Tazawa, S., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.9405 · Cited by 2
Molecular Genetics of Malignant Mesothelioma
Sekido, Y. (2012) · Wiley eBooks · doi:10.1002/9780470015902.a0022448 · Cited by 2
Self-citationTGF-b synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth
Fujii, M., Toyoda, T., Nakanishi, H., Yatabe, Y., Sato, A., Matsudaira, Y., Ito, H. M., Murakami, H., Kondo, Y., Kondo, E., et al. (2012) · The Journal of Cell Biology · doi:10.1083/jcb1964oia4 · Cited by 1
Self-citationThe Immune System of Mesothelioma Patients: A Window of Opportunity for Novel Immunotherapies
Nicolini, F., & Mazza, M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98617 · Cited by 1
The Role of VGLL4 in Development and Progression of Tumors
Yu, W. (2023) · Advances in Clinical Toxicology · doi:10.23880/act-16000288 · Cited by 1
Metadata
- Authors
- Fujii, M., Toyoda, T., Nakanishi, H., Yatabe, Y., Sato, A., Matsudaira, Y., Ito, H., Murakami, H., Kondo, Y., Kondo, E., Hida, T., Tsujimura, T., Osada, H., & Sekido, Y.
- Affiliations
- Aichi Cancer Center (JP)
- National Institute of Health Sciences (JP)
- Hyogo Medical University (JP)
- Corresponding author
- Fujii, Makiko
- Sekido, Yoshitaka
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2012-02-13
- Volume
- 209
- Issue
- 3
- Pages
- 479-494
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3302232
- OpenAlex
- W2100842035
- Cited by
- 224
- References
- 47
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 18 · 2023: 10 · 2022: 19 · 2021: 23 · 2020: 21 · 2019: 19 · 2018: 30 · 2017: 14 · 2016: 16 · 2015: 16 · 2014: 12 · 2013: 9 · 2012: 4
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- Takeda Science Foundation (H18-1-3-3-1)
- Ministry of Education, Culture, Sports, Science and Technology (H18-1-3-3-1)
- Kobayashi Foundation for Cancer Research
- Aichi Cancer Research Foundation
- Vlaamse regering
- Japan Society for the Promotion of Science (23592788, H18-1-3-3-1, 22590375, 22700935, 22300338, 21590457, 20590420, 23590438)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- malignant mesothelioma, TGF-beta signaling, Hippo signaling pathway, connective tissue growth factor, YAP, neurofibromatosis type 2, Merlin, Smad3, TEAD4, P300, extracellular matrix deposition, tumor growth, asbestos, therapeutic target
- MeSH terms
- Animals, Base Sequence, DNA, Neoplasm, Extracellular Matrix, Female, Humans, Mesothelioma, Mice, Nude, Molecular Sequence Data, Nuclear Proteins, Promoter Regions, Genetic, Transcription Factors, Signal Transduction, Transcriptional Activation, Gene Expression, Transforming Growth Factor beta, Genes, Neurofibromatosis 2, Cell Cycle Proteins, Cell Line, Tumor, Cell Proliferation, Mice, Smad Proteins, Connective Tissue Growth Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.